Alentis Therapeutics’ Post

View organization page for Alentis Therapeutics, graphic

7,587 followers

Today we announced two presentations at the European Renal Association (ERA) and American Thoracic Society (ATS) conferences this May. The outstanding work performed by the research groups at @KULeuven and @Inserm show that #CLDN1 plays a key role in the early pathogenesis of #fibrosis. It further validates CLDN1 as a therapeutic target across fibrotic indications, in this case #IPF and crescentic #glomerulonephritis in ANCA-associated vasculitis. Read the full release: https://lnkd.in/ehzix_xk #AlentisTherapeutics #ERA24 #ATS2024 #Nephrology #Claudin

  • No alternative text description for this image

To view or add a comment, sign in

Explore topics